Updated February 5 at 6:25pm
Browse
6486 results total, viewing 6211 - 6220
Research: PBN/Elizabeth W. Lorenz Photography: PBN/KATE WHITNEY LUCEY Map: PBN/Lisa Lagreca more
PROVIDENCE – Thanks largely to general revenue exceeding estimates and state agencies spending under budget in fiscal 2015, Rhode Island has a surplus for the year that is $47.8 million larger than anticipated, bringing the total surplus for the … more
In a marketplace where big insurers like Geico connect directly with consumers, The Egis Group has gained a foothold as an independent property and casualty insurance agency linking insurers and consumers. Built largely on word-of-mouth … more
Before he opened Cloud City Drones in Warwick, Christopher Williams toyed with the idea of calling it by another name, anything other than "drone." The problem, he explained, is the word "drone" conjures up frightening associations. "It has … more
1 What in your professional background has best prepared you for the new role? During my years as a private-equity real estate portfolio manager my fund was, by design, overweighted to properties in urban neighborhoods. … The investment … more
The 5.3-acre Victory Place site on Eddy Street has been purchased by Rhode Island Hospital, a transaction sought by the hospital for more than a year. more
Japan’s biggest power utilities are pushing ahead with plans to spend more on new turbines to improve the efficiency of their gas-fired power plants in an effort to lower fuel bills amid a protracted debate over the role of nuclear power. more
U.S. stocks advanced, amid their steepest losing streak in four years, as investors made another go at finding a floor after yesterday’s early rally evaporated. more
Orders for capital goods increased in July by the most in more than a year, showing corporate spending was finding its footing prior to the turmoil in financial markets. more
Novartis AG began selling the first copy of a biotechnology drug in the U.S., offering a 15 percent discount to the original after a U.S. appeals court rejected Amgen Inc.’s last-ditch effort to protect its blockbuster cancer drug Neupogen. more
« Prev | 1 619 | 620 | 621 | 622 | 623 | 624 | 625 649 | Next »